Deal facts
- Buyer
- Scott Livingston
- Target
- Mindflair plc
- Deal value
- GBP 193,409
- Announced
- 28 July 2026
- Status
- Firm intention
- Sector
- Healthcare
- Country
- Not stated
- Consideration
- cash
Sources
Scott Livingston has agreed to acquire the assets of Mindflair plc in a cash transaction valued at 193,409 GBP. The deal, announced on 28 July 2026, involves the purchase of specific business assets rather than a full equity takeover. This structure is classified as an asset sale within the healthcare sector. The consideration is provided entirely in cash, with no shares or other instruments involved in the exchange. The headline offer figure represents the total value agreed upon by both parties for the acquisition of these assets.
The transaction is currently at the firm intention stage. Both parties have expressed a clear commitment to proceed with the deal, but it has not yet been completed. The completion date remains unreported and is subject to further developments. Regulatory approvals or other conditions may need to be satisfied before the transfer of assets can be finalised. This stage indicates that the deal is progressing but is not yet legally closed. The focus remains on the successful transfer of the healthcare assets from Mindflair plc to Scott Livingston under the agreed terms.
More M&A Tools
Explore the Toolkit
Tools, frameworks and AI assistants designed for entrepreneurs serious about M&A.
Access nowDeal timeline
1 update- Firm intention
Disposal of non-core shareholding in Mindflair plc
Disclaimer* 28 July 2026 Tooru plc ("Tooru" or the "Company") Disposal of non-core shareholding in Mindflair plc Tooru, the AIM listed company focused on the branded health and wellness sector, announces that it has agreed to sell its entire shareholding of 42,979,737 shares in Mindflair plc ("Mindflair") to the Company's CEO, Scott Livingston, at a price of 0.45
LSE RNS
Explore
Browse adjacent archives
Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.
Similar deals
Similar deals
Other Healthcare M&A activity tracked by Exit Mode.
Laboratory Corporation of America Holdings to acquire BioReference Health, LLC
Laboratory Corporation of America Holdings has agreed to acquire BioReference Health, LLC in a transaction valued at 722 million US dollars. The deal, announced on 14 Oc…
- Buyer
- Laboratory Corporation of America Holdings
- Target
- BioReference Health, LLC
- Deal value
- USD 722,000,000
- Deal type
- asset sale
Silo Pharma, Inc. to acquire Larry King
Silo Pharma, Inc. has completed the acquisition of assets from Larry King. The transaction, which was announced on 14 October 2026, was finalized on 13 October 2026. Bot…
- Buyer
- Silo Pharma, Inc.
- Target
- Larry King
- Deal value
- Not disclosed
- Deal type
- asset sale
Silo Pharma, Inc. to acquire Norsight Consulting Inc.
Silo Pharma, Inc. has agreed to acquire assets from Norsight Consulting Inc. in a transaction announced on 2 October 2026. Both companies are based in the United States…
- Buyer
- Silo Pharma, Inc.
- Target
- Norsight Consulting Inc.
- Deal value
- Not disclosed
- Deal type
- asset sale
JOINT Corp to acquire The Joint Franchises San Antonio, LLC, The Joint Franchises DFW, LLC, The Joint Franchises Houston, LLC, The Joint Franchises Austin, LLC, and The Joint Franchises Texas, Ltd.
JOINT Corp has agreed to acquire a portfolio of five Texas-based entities from The Joint franchise network. The transaction, announced and completed on 1 October 2026, i…
- Buyer
- JOINT Corp
- Target
- The Joint Franchises San Antonio, LLC, The Joint Franchises DFW, LLC, The Joint Franchises Houston, LLC, The Joint Franchises Austin, LLC, and The Joint Franchises Texas, Ltd.
- Deal value
- USD 8,000,000
- Deal type
- asset sale
Element Biosystems, LLC to acquire Standard BioTools Inc.
Element Biosystems, LLC has agreed to acquire Standard BioTools Inc. in a cash asset sale. The transaction was announced on 30 September 2026 and is valued at five milli…
- Buyer
- Element Biosystems, LLC
- Target
- Standard BioTools Inc.
- Deal value
- USD 5,500,000
- Deal type
- asset sale
Buyer history
Scott Livingston
See every published Exit Mode archive entry where this buyer appears.
View buyer profileMethodology
How this page is built
Layer 1 facts come from source documents, Layer 2 turns those facts into a readable narrative, and Layer 3 only appears where the editorial team flags a founder-relevant deal.
Back to the archive